Alexey Zumbana
Founder & Chief Executive Officer (CEO)
As the Founder and CEO, Alexey Zumbana leads the overall strategy of the company, overseeing all key operations and ensuring that scientific and commercial goals align with the vision of technological innovation in apheresis. He is responsible for integrating scientific advancements into the development of products and services, and he leads collaboration across various research, manufacturing, and clinical operations areas. Under his leadership, the company has established high standards of quality and effectiveness in apheresis treatments.